Trials / Withdrawn
WithdrawnNCT05462054
Natural History Study in Pediatric Patients with STXBP1 Encephalopathy with Epilepsy
A Phase 0 Non-interventional, Multi-center, Natural History Study in Pediatric Patients with Syntaxin Binding Protein 1 (STXBP1) Encephalopathy with Epilepsy
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Capsida Biotherapeutics, Inc. · Industry
- Sex
- All
- Age
- 1 Day – 5 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, non-interventional, longitudinal study designed to characterize the natural history of STXBP1 related encephalopathy with epilepsy, in participants ≤ \<5 years of age.
Conditions
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2026-01-01
- Completion
- 2026-01-01
- First posted
- 2022-07-18
- Last updated
- 2024-10-18
Source: ClinicalTrials.gov record NCT05462054. Inclusion in this directory is not an endorsement.